000 | 02016 a2200493 4500 | ||
---|---|---|---|
005 | 20250518063412.0 | ||
264 | 0 | _c20201030 | |
008 | 202010s 0 0 eng d | ||
022 | _a1524-4725 | ||
024 | 7 |
_a10.1097/DSS.0000000000002165 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCartier, Hugues | |
245 | 0 | 0 |
_aRepeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler. _h[electronic resource] |
260 |
_bDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] _c04 2020 |
||
300 |
_a475-482 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcholine Release Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBotulinum Toxins, Type A _xadministration & dosage |
650 | 0 | 4 |
_aCombined Modality Therapy _xmethods |
650 | 0 | 4 | _aCosmetic Techniques |
650 | 0 | 4 |
_aDermal Fillers _xadministration & dosage |
650 | 0 | 4 | _aEsthetics |
650 | 0 | 4 | _aFace |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyaluronic Acid _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Satisfaction |
650 | 0 | 4 | _aRejuvenation |
650 | 0 | 4 |
_aRetreatment _xmethods |
650 | 0 | 4 | _aSkin Aging |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHedén, Per | |
700 | 1 | _aDelmar, Henry | |
700 | 1 | _aBergentz, Per | |
700 | 1 | _aSkoglund, Cecilia | |
700 | 1 | _aEdwartz, Carolina | |
700 | 1 | _aNorberg, Maria | |
700 | 1 | _aKestemont, Philippe | |
773 | 0 |
_tDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] _gvol. 46 _gno. 4 _gp. 475-482 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/DSS.0000000000002165 _zAvailable from publisher's website |
999 |
_c30182415 _d30182415 |